BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 811195)

  • 1. Mitral valve replacement with the Hancock stabilized glutaraldehyde valve. Clinical and laboratory evaluation.
    Buch WS; Pipkin RD; Hancock WD; Fogarty TJ
    Arch Surg; 1975 Nov; 110(11):1408-15. PubMed ID: 811195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Hancock "stabilized glutaraldehyde process" bioprosthesis in the management of mitral valve disease.
    Litwak RS; Hancock WD; Lukban SB; Jurado RA
    Adv Cardiol; 1977; 20():90-101. PubMed ID: 403748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with a porcine aortic valve xenograft for mitral valve replacement.
    Stinson EB; Griepp RB; Shumway NE
    Ann Thorac Surg; 1974 Oct; 18(4):391-401. PubMed ID: 4278733
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart valve replacement with the Hancock bioprosthesis. Analysis of long-term results.
    Cévese PG; Gallucci V; Morea M; Dalla Volta S; Fasoli G; Casarotto D
    Circulation; 1977 Sep; 56(3 Suppl):II111-6. PubMed ID: 407032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early mechanical failures of the Hancock pericardial xenograft.
    Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structural changes of Hancock bioprostheses in children (author's transl)].
    Bortolotti U; Milano A; Mazzucco A; Callucci V; Valente M; Del Maschio A; Valfrè C; Thiene G
    G Ital Cardiol; 1980; 10(11):1520-5. PubMed ID: 7202899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral valve replacement with glutaraldehyde preserved aortic allografts.
    Salles CA; Buffolo E; Andrade JC; Palma JH; Silva RR; Santiago R; Casagrande IS; Moreira MC
    Eur J Cardiothorac Surg; 1998 Feb; 13(2):135-43. PubMed ID: 9583818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of the Björk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses.
    Bloomfield P; Kitchin AH; Wheatley DJ; Walbaum PR; Lutz W; Miller HC
    Circulation; 1986 Jun; 73(6):1213-22. PubMed ID: 3516447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrioventricular valve replacement with the Hancock porcine xenograft: a five year clinical experience.
    McIntosh CL; Michaelis LL; Morrow AG; Itscoitz SB; Redwood DR; Epstein SE
    Surgery; 1975 Dec; 78(6):768-75. PubMed ID: 810904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of survival and valve failure after mitral valve replacement.
    Teoh KH; Ivanov J; Weisel RD
    Ann Thorac Surg; 1990 Apr; 49(4):643-8. PubMed ID: 2322061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic complications after mitral valve replacement with Hancock xenograft.
    Hetzer R; Hill JD; Kerth WJ; Ansbro J; Adappa MG; Rodvien R; Kamm B; Gerbode F
    J Thorac Cardiovasc Surg; 1978 May; 75(5):651-8. PubMed ID: 565444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac valve replacement with the stabilized glutaraldehyde porcine aortic valve: indications, operative results, and followup.
    Cohn LH; Lambert JJ; Castaneda AR; Collins JJ
    Chest; 1975 Aug; 68(2):162-5. PubMed ID: 807455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated mitral valve replacement with the Hancock porcine bioprosthesis in rheumatic heart disease: analysis of 213 operative survivors followed up 4.5 to 8.5 years.
    Gallo I; Ruiz B; Durán CG
    Am J Cardiol; 1984 Jan; 53(1):178-81. PubMed ID: 6691258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitral valve replacement with the glutaraldehyde-preserved porcine heterograft. Clinical, hemodynamic, and pathological correlations.
    Horowitz MS; Goodman DJ; Fogarty TJ; Harrison DC
    J Thorac Cardiovasc Surg; 1974 Jun; 67(6):885-95. PubMed ID: 4208082
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term experience with porcine aortic valve xenografts.
    Stinson EB; Griepp RB; Oyer PE; Shumway NE
    J Thorac Cardiovasc Surg; 1977 Jan; 73(1):54-63. PubMed ID: 556634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic and echocardiographic investigations following mitral valve replacement by glutaraldehyde preserved xenografts (author's transl)].
    Deltz E; Mattern A; Fricke G; Bernhard A
    Thoraxchir Vask Chir; 1978 Feb; 26(1):52-6. PubMed ID: 414374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral valve replacement with Hancock porcine bioprostheses: up to 7-year follow-up.
    Brais MP; Bédard JP; Goldstein W; Koshal A; Keon WJ
    Can J Surg; 1985 Mar; 28(2):119-21, 123. PubMed ID: 3971234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actuarial comparison of Hancock porcine and prosthetic disc valves for isolated mitral valve replacement.
    Cohn LH; Sanders JH; Collins JJ
    Circulation; 1976 Dec; 54(6 Suppl):III60-3. PubMed ID: 1033048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for acquired valvular heart disease. 2.
    Kirklin JW; Pacifico AD
    N Engl J Med; 1973 Jan; 288(4):194-9. PubMed ID: 4565853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.